+919405117673
Buy Tegafur + Gimeracil + Oteracil 15mg/20mg Capsules for International Oncology Supply
Tegafur + Gimeracil + Oteracil Capsules (commonly known as S-1 oral chemotherapy capsules) are advanced oral anti-cancer medicines widely used in oncology protocols for gastric and other solid tumors. These capsules combine three active ingredients that work together to improve anticancer effectiveness while reducing gastrointestinal toxicity. The formulation is commonly used in oncology treatment protocols involving stomach cancer and selected advanced cancers under specialist supervision.

As a trusted exporter and supplier of oncology medicines, we provide Tegafur + Gimeracil + Oteracil 15mg and 20mg capsules for hospitals, distributors, oncology pharmacies, government tenders, and pharmaceutical importers across major global markets.

Target Export Markets:
United States | Germany | United Kingdom | UAE | Brazil | South Africa

Product Overview

Product Name: Tegafur + Gimeracil + Oteracil Capsules
Strength Variants:

Tegafur 15mg + Gimeracil 4.35mg + Oteracil 11.8mg
Tegafur 20mg + Gimeracil 5.8mg + Oteracil 15.8mg

Dosage Form: Oral Capsules
Category: Anti-Cancer / Oncology Medicine
Therapeutic Segment: Oral Chemotherapy Capsules
Packaging: Export Packaging Available
Prescription Requirement: Oncology Specialist Prescription Required

Key Features of Tegafur + Gimeracil + Oteracil Capsules

✔ Oral chemotherapy alternative for selected oncology regimens
✔ Designed to maintain prolonged active drug exposure in the body
✔ Developed to reduce gastrointestinal toxicity compared to conventional fluoropyrimidine therapy approaches
✔ Available in export-friendly packaging options
✔ Bulk supply available for international pharmaceutical buyers
✔ Suitable for oncology hospitals, distributors, and procurement agencies

Medical Uses & Oncology Applications

Tegafur + Gimeracil + Oteracil capsules are primarily used in treatment protocols for:

Advanced gastric cancer
Metastatic stomach cancer management
Selected gastrointestinal malignancies
Certain colorectal oncology protocols
Other solid tumor treatments under oncology supervision

This combination medicine works by converting Tegafur into active fluorouracil (5-FU), while Gimeracil prolongs drug exposure and Oteracil helps reduce gastrointestinal side effects.

Why International Buyers Source Tegafur + Gimeracil + Oteracil from India

India continues to be a preferred source for oncology medicine exports because of:

Competitive export pricing
Reliable oncology manufacturing ecosystem
Large-scale production capacity
Regulatory documentation support
Global shipping capabilities
Flexible MOQ options for importers

We support pharmaceutical buyers seeking:

Oncology medicine exporters in India
Bulk oncology capsule suppliers
Anti-cancer medicine wholesalers
Oral chemotherapy exporters
Global oncology distributors
Cancer medicine procurement companies

Countries We Serve
United States Oncology Market

Supply support for pharmaceutical importers, specialty pharmacies, oncology distributors, and procurement agencies.

Germany & United Kingdom

Serving oncology medicine buyers seeking reliable suppliers for regulated pharmaceutical sourcing.

UAE Pharmaceutical Buyers

Supporting hospital procurement teams, distributors, and oncology medicine importers.

Brazil Oncology Supply Chain

Reliable supply solutions for wholesalers and cancer medicine procurement companies.

South Africa Healthcare Sector

Serving importers and distributors requiring oncology capsule supply solutions.

Storage & Handling
Store below recommended temperature conditions
Keep away from moisture and direct sunlight
Handle according to oncology medicine safety protocols
Use only under specialist supervision

Request Bulk Orders & Export Enquiries

For distributor pricing, bulk purchases, export quotations, and international shipping support:

WhatsApp: +91-9405117673
Email: info@cordiumpharma.com

Connect with us for reliable global supply of Tegafur + Gimeracil + Oteracil 15mg/20mg Capsules for oncology markets worldwide.
May 29th, 2026 11:46 AM

Keywords